Hepatitis E virus infection in anti-HEV IgG-carryinfing patients after successful HCV treatment: reactivation or reinfection? | Zendy

Antonio RiveroJuárez | Zendy; Mario Frías | Zendy; Pedro LópezLópez | Zendy; María Á. Risalde | Zendy; Teresa Brieva | Zendy; Isabel Machuca | Zendy; Ángela Camacho | Zendy; Antonio Martínez-Peinado | Zendy; J.C. Gómez-Villamandos | Zendy; Antonio Rivero | Zendy

Open Access

Hepatitis E virus infection in anti-HEV IgG-carryinfing patients after successful HCV treatment: reactivation or reinfection?

Author(s) -

Antonio RiveroJuárez,

Mario Frías,

Pedro LópezLópez,

María Á. Risalde,

Teresa Brieva,

Isabel Machuca,

Ángela Camacho,

Antonio Martínez-Peinado,

J.C. Gómez-Villamandos,

Antonio Rivero

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix004

Subject(s) - medicine , hepatitis e virus , virology , antibody , immunology , virus , hepatitis c virus , pathogenesis , biology , genotype , biochemistry , gene

Although hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research